Literature DB >> 9834215

Influence of cytokines on the growth kinetics and immunophenotype of daughter cells resulting from the first division of single CD34(+)Thy-1(+)lin- cells.

J P Goff1, D S Shields, J S Greenberger.   

Abstract

There is a need to determine whether culture conditions may exist for ex vivo expansion of hematopoeitic stem cells (HSC), which favor solely proliferative self-renewal of HSC as opposed to proliferation with differentiation. Using single cells, we studied the effects of individual and combinations of cytokines in serum-free medium on the kinetics of the first cell doubling and the resulting phenotype of each of individual daughter cell. CD34(+)Thy-1(+)lin- cells were plated 1 cell per well in Terasaki plates in serum-free medium containing cytokines. Each well containing a single cell was monitored daily over 7 days for maintenance, division, or death. When division occurred in an individual well, the phenotype of the daughter cells was determined by staining with anti-CD34 fluorescein isothiocyanate (FITC)- and phycoerythrin (PE)-conjugated lineage specific antibodies. The cumulative percent of wells with an undivided single cell, wells in which the cell had divided, and wells in which the cell had died were scored. The number of doublets with conserved phenotype (CD34(+)lin-) was compared to those wells with one or more differentiated daughter cells (CD34(+)lin+). Over 7 days, cells cultured in single factors showed that between 13% (interleukin-6 [IL-6]) and 29% (thrombopoietin [TPO]) of the cells were undivided, between 13% (IL-1) and 35% (TPO) of the cells doubled, and between 35% (TPO) and greater than 60% (IL-11, IL-1, or hepatocyte growth factor [HGF]) died. When combinations of cytokines were used over 7 days, between 5% (FLT-3 ligand [FLT-3L], stem cell factor [SCF], IL-3, IL-6, granulocyte colony-stimulating factor [G-CSF], beta nerve growth factor [betaNGF]) and 22% (FLT-3L + HGF) of the cells remained undivided, between 15% (HGF, IL-1, IL-11, G-CSF) and 68% (SCF + TPO) of the cells had doubled and between 27% (FLT-3L + TPO) and 70% (HGF, IL-1, IL-11, G-CSF) died. The combination of FLT-3L + TPO induced the highest total percent (64. 6%) of cells with conserved phenotype (percent conserved doublets + percent with 1 cell conserved), followed by SCF + TPO, (50%) and the combination of FLT-3L, SCF, IL-3, IL-6, G-CSF, betaNGF (53%). These combinations also produced the highest yield of cells with conserved phenotype after one division (FLT-3L + TPO - 81 cells/100 initial cells, SCF + TPO - 68 cells/100 initial cells) (P =.01). Observation of the time of the initial cell division and phenotype of the daughter cells allowed us to identify candidate combinations of cytokines that promote maintenance of lin- cells (TPO), or recruit the primitive cells to divide and undergo phenotypic self-renewal (FLT-3L + TPO, SCF + TPO).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9834215

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

Review 1.  Novel chemical attempts at ex vivo hematopoietic stem cell expansion.

Authors:  Yu Zhang; Yingdai Gao
Journal:  Int J Hematol       Date:  2016-02-24       Impact factor: 2.490

2.  The cross-talk between ROS and p38MAPKα in the Ex Vivo expanded human umbilical cord blood CD133(+) cells.

Authors:  Jing Zou; Ping Zou; Yi Lou; Yin Xiao; Jie Wang; Lingbo Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-10-25

3.  Ionizing irradiation protection and mitigation of murine cells by carbamazepine is p53 and autophagy independent.

Authors:  Hyun Kim; Mark E Bernard; Amy Farkas; Julie Goff; Ronny Kalash; Frank Houghton; Donna Shields; Darcy Franicola; Tracy Dixon; Xichen Zhang; Michael Epperly; Hong Wang; Murat Can Cobanoglu; Joel S Greenberger
Journal:  In Vivo       Date:  2012 May-Jun       Impact factor: 2.155

4.  Hematopoietic stem cells need two signals to prevent apoptosis; BCL-2 can provide one of these, Kitl/c-Kit signaling the other.

Authors:  J Domen; I L Weissman
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

5.  Wnt3a protein reduces growth factor-driven expansion of human hematopoietic stem and progenitor cells in serum-free cultures.

Authors:  Lucia E Duinhouwer; Nesrin Tüysüz; Elwin W J C Rombouts; Mariette N D Ter Borg; Enrico Mastrobattista; Jan Spanholtz; Jan J Cornelissen; Derk Ten Berge; Eric Braakman
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

6.  Osteoblasts secrete miRNA-containing extracellular vesicles that enhance expansion of human umbilical cord blood cells.

Authors:  Jess Morhayim; Jeroen van de Peppel; Eric Braakman; Elwin W J C Rombouts; Mariette N D Ter Borg; Amel Dudakovic; Hideki Chiba; Bram C J van der Eerden; Marc H Raaijmakers; Andre J van Wijnen; Jan J Cornelissen; Johannes P van Leeuwen
Journal:  Sci Rep       Date:  2016-09-02       Impact factor: 4.379

7.  Cord blood stem cell expansion is permissive to epigenetic regulation and environmental cues.

Authors:  Hiroto Araki; Sudhakar Baluchamy; Kazumi Yoshinaga; Benjamin Petro; Sakina Petiwala; Ritesh Parajuli; Mohammed Milhem; Donald Lavelle; Joseph DeSimone; Nadim Mahmud
Journal:  Exp Hematol       Date:  2009-06-06       Impact factor: 3.084

8.  Circulation and chemotaxis of fetal hematopoietic stem cells.

Authors:  Julie L Christensen; Douglas E Wright; Amy J Wagers; Irving L Weissman
Journal:  PLoS Biol       Date:  2004-03-16       Impact factor: 8.029

9.  Angiopoietin-like protein 3 promotes preservation of stemness during ex vivo expansion of murine hematopoietic stem cells.

Authors:  Elnaz Farahbakhshian; Monique M Verstegen; Trudi P Visser; Sima Kheradmandkia; Dirk Geerts; Shazia Arshad; Noveen Riaz; Frank Grosveld; Niek P van Til; Jules P P Meijerink
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

10.  Antioxidant Small Molecule Compound Chrysin Promotes the Self-Renewal of Hematopoietic Stem Cells.

Authors:  Yinghui Li; Mei He; Wenshan Zhang; Ming Yang; Yahui Ding; Shiqi Xu; Jiali Gu; Yafang Li; Jingjing Yin; Yingdai Gao
Journal:  Front Pharmacol       Date:  2020-04-02       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.